Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 17;10(5):789.
doi: 10.3390/antiox10050789.

Clinical Significance of Heme Oxygenase 1 in Tumor Progression

Mariapaola Nitti  1 , Caterina Ivaldo  1 , Nicola Traverso  1 , Anna Lisa Furfaro  1
Affiliations
Review

Clinical Significance of Heme Oxygenase 1 in Tumor Progression

Mariapaola Nitti et al. Antioxidants (Basel). .

Abstract

Heme oxygenase 1 (HO-1) plays a key role in cell adaptation to stressors through the antioxidant, antiapoptotic, and anti-inflammatory properties of its metabolic products. For these reasons, in cancer cells, HO-1 can favor aggressiveness and resistance to therapies, leading to poor prognosis/outcome. Genetic polymorphisms of HO-1 promoter have been associated with an increased risk of cancer progression and a high degree of therapy failure. Moreover, evidence from cancer biopsies highlights the possible correlation between HO-1 expression, pathological features, and clinical outcome. Indeed, high levels of HO-1 in tumor specimens often correlate with reduced survival rates. Furthermore, HO-1 modulation has been proposed in order to improve the efficacy of antitumor therapies. However, contrasting evidence on the role of HO-1 in tumor biology has been reported. This review focuses on the role of HO-1 as a promising biomarker of cancer progression; understanding the correlation between HO-1 and clinical data might guide the therapeutic choice and improve the outcome of patients in terms of prognosis and life quality.

Keywords: HO-1; Nrf2; biomarker; cancer progression; patients; prognosis; therapy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic representation of heme oxygenase 1 (HO-1) activity and regulation. HO-1 induction can be regulated at the transcriptional level by several stress-related transcription factors (Nrf2, AP-1, NF-kB, and HIF-1). Two polymorphisms that modify HO-1 inducibility have been indicated. Post-transcriptional regulation can involve miRNA. HO-1 regulates intracellular heme level catalyzing its degradation into biliverdin, carbon monoxide (CO), and ferrous iron (Fe2+). Biliverdin is converted into bilirubin by biliverdin reductase A (BVRA). Free iron activates iron transporters and induces the expression of ferritin. HO-1 metabolic products exert pro-survival activities, as indicated. A truncated form of HO-1, formed by signal peptide peptidase (SSP) cleavage, with nuclear localization and no enzymatic activity, has been described.
Figure 2
Figure 2
Schematic representation of the effects of HO-1 activation and generation of its metabolic products in healthy and cancer cells. HO-1 activation is involved in antioxidant defenses and in healthy cells promotes the hormetic response and cancer prevention through the generation of bilirubin and CO. In cancer cells, HO-1 favors cancer progression, and its inhibition represents a therapeutic opportunity. However, also HO-1 over-activation can be proposed as a therapeutic option, as it can favor unconventional ferroptosis through the accumulation of pro-oxidant-free iron.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Maines M.D. Heme Oxygenase: Function, Multiplicity, Regulatory Mechanisms, and Clinical Applications. FASEB J. 1988;2:2557–2568. doi: 10.1096/fasebj.2.10.3290025. - DOI - PubMed
    1. Waza A.A., Hamid Z., Ali S., Bhat S.A., Bhat M.A. A Review on Heme Oxygenase-1 Induction: Is It a Necessary Evil. Inflamm. Res. 2018;67:579–588. doi: 10.1007/s00011-018-1151-x. - DOI - PubMed
    1. Kutty R.K., Nagineni C.N., Kutty G., Hooks J.J., Chader G.J., Wiggert B. Increased Expression of Heme Oxygenase-1 in Human Retinal Pigment Epithelial Cells by Transforming Growth Factor-Beta. J. Cell Physiol. 1994;159:371–378. doi: 10.1002/jcp.1041590221. - DOI - PubMed
    1. Bian C., Zhong M., Nisar M.F., Wu Y., Ouyang M., Bartsch J.W., Zhong J.L. A Novel Heme Oxygenase-1 Splice Variant, 14kDa HO-1, Promotes Cell Proliferation and Increases Relative Telomere Length. Biochem. Biophys Res. Commun. 2018;500:429–434. doi: 10.1016/j.bbrc.2018.04.096. - DOI - PubMed
    1. Furfaro A.L., Traverso N., Domenicotti C., Piras S., Moretta L., Marinari U.M., Pronzato M.A., Nitti M. The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance. Oxid. Med. Cell. Longev. 2016;2016:1958174. doi: 10.1155/2016/1958174. - DOI - PMC - PubMed

LinkOut - more resources